Ruiz-Cobo, J. C., Llaneras, J., Forns, X., Gallego Moya, A., Conde Amiel, I., Arencibia, A., . . . Buti, M. (2024). Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.
Citación estilo ChicagoRuiz-Cobo, Juan Carlos, et al. Real-life Effectiveness of Sofosbuvir/velpatasvir/voxilaprevir in Hepatitis C Patients Previously Treated With Sofosbuvir/velpatasvir or Glecaprevir/pibrentasvir. 2024.
Cita MLARuiz-Cobo, Juan Carlos, et al. Real-life Effectiveness of Sofosbuvir/velpatasvir/voxilaprevir in Hepatitis C Patients Previously Treated With Sofosbuvir/velpatasvir or Glecaprevir/pibrentasvir. 2024.
Precaución: Estas citas no son 100% exactas.